News Nov 18, 2024 Alimentiv Partners on a New Alcoholic Hepatitis Phase 1b Clinical Trial September 2024 – Alimentiv is proud to partner on an exciting new Phase 1b clinical trial in severe alcohol-associated hepatitis, an area with high mortality… Read Now
Publication Nov 6, 2024 Efficacy and Safety of Advanced Combination Treatment in Immune-Mediated Inflammatory Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Christopher Ma, Vipul Jairath, Virginia Salitano Read Now
Publication Jun 8, 2017 A Comparison of Approaches for Adjudicating Outcomes in Clinical Trials Brian Feagan, Vipul Jairath Read Now
Publication Jun 1, 2017 Randomised Non-inferiority Trial: 1600 MG Versus 400 MG Tablets of Mesalazine for the Treatment of Mild-To-Moderate Ulcerative Colitis Geert D’Haens, Guangyong Zou, Vipul Jairath Read Now
Publication May 27, 2017 Histologic Scoring Indices for Evaluation of Disease Activity in Ulcerative Colitis Brian Feagan, Guangyong Zou, Vipul Jairath Read Now
Publication May 10, 2017 The Evolution of Treatment Paradigms in Crohn’s Disease: Beyond Better Drugs Brian Feagan, Vipul Jairath Read Now
Publication Mar 11, 2017 Incidence, Prevention and Management of Anti-Drug Antibodies Against Therapeutic Antibodies in Inflammatory Bowel Disease: A Practical Overview Brian Feagan, Vipul Jairath Read Now
Publication Mar 5, 2017 The Safety of Vedolizumab for the Treatment of Ulcerative Colitis Brian Feagan, Vipul Jairath Read Now
